Mirum Pharmaceuticals, Inc. Common Stock (MIRM) is a publicly traded Healthcare sector company. As of May 21, 2026, MIRM trades at $96.95 with a market cap of $5.82B and a P/E ratio of -7.07. MIRM moved +1.44% today. Year to date, MIRM is +28.31%; over the trailing twelve months it is +113.83%. Its 52-week range spans $36.88 to $114.99. Analyst consensus is strong buy with an average price target of $146.00. Rallies surfaces MIRM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MIRM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MIRM recently traded at $96.95. Market cap is $5.82B. P/E ratio is -7.07. Revenue is $569.61M.
| Metric | Value |
|---|---|
| Price | $96.95 |
| Market Cap | $5.82B |
| P/E Ratio | -7.07 |
| EPS | $-13.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $114.99 |
| 52-Week Low | $36.88 |
| Volume | 465 |
| Avg Volume | 0 |
| Revenue (TTM) | $569.61M |
| Net Income | $-798.84M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $521.31M | $-23.36M | $-0.47 |
| 2024 | $336.89M | $-87.94M | $-1.85 |
| 2023 | $186.37M | $-163.41M | $-4.00 |
| 2022 | $77.06M | $-135.66M | $-4.01 |
11 analysts cover MIRM: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $146.00.